Inventiva (IVA) Non-Current Assets (2018 - 2025)

Inventiva (IVA) recorded quarterly Non-Current Assets of $5.9 million in Q4 2025, down 99.92% quarter-over-quarter from $7.0 billion in Q2 2025, and down 26.34% on a YoY basis from $8.0 million in Q4 2024.

Inventiva (IVA) Non-Current Assets (2018 - 2025) Analysis & Trends

Inventiva's Non-Current Assets history runs 8 years deep, the most recent figure standing at $5.9 million for Q4 2025.

  • In Q4 2025, Non-Current Assets fell 26.34% year-over-year to $5.9 million; the TTM figure through Dec 2025 stood at $5.9 million (down 26.34% YoY), while the FY2025 annual figure was $5.9 million, down 26.34% from the prior year.
  • Non-Current Assets was $5.9 million for Q4 2025 at Inventiva, down from $7.0 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $9.0 billion in Q2 2022 to a low of $5.9 million in Q4 2025.
  • Historically, Non-Current Assets has averaged $1.6 billion across 5 years, with a median of $9.4 million in 2022.
  • The sharpest annual moves came in 2022 and 2024: Non-Current Assets surged 101451.95% in 2022, then slumped 65.35% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $7.3 million in 2021, then surged by 33.9% to $9.8 million in 2022, then soared by 134.25% to $23.0 million in 2023, then plunged by 65.35% to $8.0 million in 2024, then declined by 26.34% to $5.9 million in 2025.
  • The last three Non-Current Assets figures came in at $5.9 million (Q4 2025), $7.0 billion (Q2 2025), and $8.0 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - 62,953.78
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 4.56 Mn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 486.60 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 30.30 Mn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 14.75 Bn
9 Abivax 95.45 Bn 95.45 Bn - 39.71 Mn
10 Inventiva 8.93 Mn -259.80 Mn - 5.87 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 5.87 Mn
Jun 30, 2025 6.95 Bn
Dec 31, 2024 7.97 Mn
Jun 30, 2024 18.54 Mn
Dec 31, 2023 22.99 Mn
Dec 31, 2022 9.82 Mn
Jun 30, 2022 9.03 Bn
Dec 31, 2021 7.33 Mn
Jun 30, 2021 8.89 Mn
Mar 31, 2021 8.21 Mn
Dec 31, 2020 7.06 Mn
Jun 30, 2020 9.42 Mn
Dec 31, 2019 8.95 Mn
Dec 31, 2018 9.33 Mn